The latest trend in metabolic health is undoubtedly centered around GLP-1 receptor agonists , and BrightMeds is at the forefront of this movement . These groundbreaking drugs, initially developed for treating type 2 diabetes, are now widely prescribed – or being explored – for their impressive ability to promote reduced body fat and improve ove